2m 2m 2m 2m 2m 2m 2m
ARS Pharma (SPRY)
NASDAQ
$7.78+$0.04 (+0.45%)
Price as of Jul 14, 2026 6:04 AM EDT- $768.6MMarket Cap
- -56.76%1-Year Change
- BiotechnologyIndustry
ARS Pharma (SPRY)
$7.78+$0.04 (+0.45%)
SPRY | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.74 | ||
Change | -$0.20 (-2.52%) | ||
Open | $7.85 | ||
High | $7.87 | ||
Low | $7.49 | ||
Previous Close | $7.94 | ||
Volume | 1,399,987 | ||
30-Day Average Volume | 2,010,317 | ||
1-Week Change | -7.08% | ||
1-Month Change | -20.70% | ||
1-Year Change | -56.76% | ||
3-Year Change | 12.50% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 99.3M | ||
Total Assets | $287.6M | ||
Market Cap | $768.6M | ||
Enterprise Value | $840.8M | ||
Period: QTR TTM FY | |||
Revenue | $17.5M | ||
Net Income | -$60.6M | ||
Free Cash Flow | -$44.9M | ||
EBIT | -$60.6M | ||
EBITDA | -$60.2M | ||
Net Working Capital | $195.6M | ||
EPS | -$0.61 | ||
Enterprise Value/EBITDA | -14 | ||
Enterprise Value/Revenue | 48 | ||
P/B | 13 | ||
P/E | -13 | ||
PEG | 0 | ||
Price/Free Cash Flow | -17 | ||
Price/Operating Cash Flow | -17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue